Pharming Group N.V. - PHAR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$2.479M
QoQ value delta ($000)
+$1.625M (+190.28%)
Implied price effect (QoQ)
+22.21%
Shares
Total shares
140,455
QoQ shares delta
+81,325 (+137.54%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PHAR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 16 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Silverberg Bernstein Capital Management LLC 893 50,547 0.52%
NewEdge Advisors, LLC 510 28,868 0.0%
MILLENNIUM MANAGEMENT LLC 360 20,385 0.0%
CITADEL ADVISORS LLC 312 17,690 0.0%
SmartHarvest Portfolios, LLC 224 12,687 0.08%
MORGAN STANLEY 136 7,700 0.0%
EverSource Wealth Advisors, LLC 15 904 0.0%
Nalls Sherbakoff Group, LLC 15 870 0.01%
BNP PARIBAS FINANCIAL MARKETS 14 800 0.0%
BESSEMER GROUP INC 0 3 0.0%
UBS Group AG 0 1 0.0%